Trial Profile
Effect of telmisartan and ramipril on atrial fibrillation recurrence and severity in hypertensive patients with metabolic syndrome and recurrent symptomatic paroxysmal and persistent atrial fibrillation.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Mar 2012
Price :
$35
*
At a glance
- Drugs Ramipril (Primary) ; Telmisartan (Primary) ; Amlodipine
- Indications Atrial fibrillation; Hypertension
- Focus Therapeutic Use
- 05 Nov 2010 New trial record.